Business Description
Parmax Pharma Ltd
ISIN : INE240T01014
Compare
Compare
Traded in other countries / regions
540359.India IPO Date
2017-03-16Description
Parmax Pharma Ltd is a pharmaceutical company. The company manufactures and sells Tablets, Capsules, Ointments, and Injectable. Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Paliperidone, Lacosamide, 2-Acetyl Benzo(B) Thiophene, Camphor Sulfonyl Chloride, 3-Methoxy Thiophene, Silodosin API, and others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.21 | |||||
| Debt-to-Equity | 1.72 | |||||
| Debt-to-EBITDA | -3.28 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.61 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.7 | |||||
| 3-Year EBITDA Growth Rate | 7.5 | |||||
| 3-Year EPS without NRI Growth Rate | -38.9 | |||||
| 3-Year Book Growth Rate | 5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.05 | |||||
| 9-Day RSI | 43.15 | |||||
| 14-Day RSI | 46.28 | |||||
| 6-1 Month Momentum % | -0.49 | |||||
| 12-1 Month Momentum % | -1.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.89 | |||||
| Quick Ratio | 0.52 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 107.42 | |||||
| Days Sales Outstanding | 29.08 | |||||
| Days Payable | 163.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.43 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.6 | |||||
| Operating Margin % | -22.47 | |||||
| Net Margin % | -31.32 | |||||
| FCF Margin % | -4.58 | |||||
| ROE % | -95.38 | |||||
| ROA % | -25.41 | |||||
| ROIC % | -25.67 | |||||
| ROC (Joel Greenblatt) % | -36.14 | |||||
| ROCE % | -35.72 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.86 | |||||
| PB Ratio | 3.57 | |||||
| Price-to-Tangible-Book | 3.5 | |||||
| Price-to-Operating-Cash-Flow | 34.19 | |||||
| EV-to-EBIT | -4.79 | |||||
| EV-to-EBITDA | -9.87 | |||||
| EV-to-Revenue | 1.25 | |||||
| EV-to-FCF | -27.74 | |||||
| Earnings Yield (Greenblatt) % | -20.89 | |||||
| FCF Yield % | -5.4 | |||||
| Forward Rate of Return (Yacktman) % | 14.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Parmax Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 131.774 | ||
| EPS (TTM) (₹) | -11.03 | ||
| Beta | 0.25 | ||
| Volatility % | 21.67 | ||
| 14-Day RSI | 46.28 | ||
| 14-Day ATR (₹) | 2.774241 | ||
| 20-Day SMA (₹) | 30.913 | ||
| 12-1 Month Momentum % | -1.77 | ||
| 52-Week Range (₹) | 24.18 - 37.9 | ||
| Shares Outstanding (Mil) | 3.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Parmax Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Parmax Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Parmax Pharma Ltd Frequently Asked Questions
What is Parmax Pharma Ltd(BOM:540359)'s stock price today?
The current price of BOM:540359 is ₹29.85. The 52 week high of BOM:540359 is ₹37.90 and 52 week low is ₹24.18.
When is next earnings date of Parmax Pharma Ltd(BOM:540359)?
The next earnings date of Parmax Pharma Ltd(BOM:540359) is .
Does Parmax Pharma Ltd(BOM:540359) pay dividends? If so, how much?
Parmax Pharma Ltd(BOM:540359) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers